A Trial of Vigil for Participants With Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Nemunaitis, MD
Gradalis, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Southern California Permanente Medical Group
Irvine, California, United States
- Palo Alto Foundation Medical Group
San Francisco, California, United States
- University of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Florida Cancer Specialists
West Palm Beach, Florida, United States
- Georgia Cancer Center at Augusta University
Augusta, Georgia, United States
- University of Kentucky Markey Cancer Center
Lexington, Kentucky, United States
- Maine Medical Center: Mmp Women'S Health
Scarborough, Maine, United States
- Dana Farber Cancer Institute: Gynecologic Oncology
Boston, Massachusetts, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Billings Clinic
Billings, Montana, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Dartmouth-Hitchcock Medical Center/norris Cotton Cancer Center
Lebanon, New Hampshire, United States
- University of New Mexico Cancer Center
Albuquerque, New Mexico, United States
- Duke University Medical Center, Department of Medicine - Oncology
Durham, North Carolina, United States
- Barrett Cancer Center University of Cincinnati Medical Center
Cincinnati, Ohio, United States
- Stephenson Cancer Center at University of Oklahoma
Oklahoma City, Oklahoma, United States
- Amd Asplundh Cancer Pavilion
Abington, Pennsylvania, United States
- St. Luke'S Health Network
Bethlehem, Pennsylvania, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Prisma Health Cancer Institute
Greenville, South Carolina, United States
- Mary Crowley Cancer Research Centers
Dallas, Texas, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
- Cancer Care Northwest
Spokane, Washington, United States
- Franciscan Research Center
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2015
- Primary completion
- 31 Dec 2028
- Completion
- 31 Dec 2028
- Last update posted
- 29 Oct 2025
- Registered enrollment
- 92
- Registry id
- NCT02346747
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.